In conclusion, this experiment reveals that rat uMDSCs can be isolated successfully and can form myotubes in vitro. PERK/ATF4 pathway was involved in myotube formation, and L6 rat myoblast cells were activated by Li-ESWT to form myotubes. These findings suggest that PERK/ATF4 pathway is activated by Li-ESWT. This study elucidates one of the biochemical pathways responsible for the clinical improvements seen after Li-ESWT. It is possible that this information will help to establish Li-ESWT as an acceptable treatment modality and may help to further refine the use of Li-ESWT in the clinical practice of medicine.
Low-intensity extracorporeal shock wave therapy (Li-ESWT) is used in the treatment of erectile dysfunction, but its mechanisms are not well understood. Previously, we found that Li-ESWT increased the expression of brain-derived neurotrophic factor (BDNF). Here we assessed the underlying signaling pathways in Schwann cells in vitro and in penis tissue in vivo after nerve injury. The result indicated that BDNF were significantly increased by the Li-ESWT after nerve injury, as well as the expression of BDNF in Schwann cells (SCs, RT4-D6P2T) in vitro. Li-ESWT activated the protein kinase RNA-like endoplasmic reticulum (ER) kinase (PERK) pathway by increasing the phosphorylation levels of PERK and eukaryotic initiation factor 2a (eIF2α), and enhanced activating transcription factor 4 (ATF4) in an energy-dependent manner. In addition, GSK2656157—an inhibitor of PERK—effectively inhibited the effect of Li-ESWT on the phosphorylation of PERK, eIF2α, and the expression of ATF4. Furthermore, silencing ATF4 dramatically attenuated the effect of Li-ESWT on the expression of BDNF, but had no effect on hypoxia-inducible factor (HIF)1α or glial cell-derived neurotrophic factor (GDNF) in Schwann cells. In conclusion, our findings shed new light on the underlying mechanisms by which Li-ESWT may stimulate the expression of BDNF through activation of PERK/ATF4 signaling pathway. This information may help to refine the use of Li-ESWT to further improve its clinical efficacy.
These results demonstrated an increased population of ICs in the BOO rat model and suggest that the functional change of ICs and NOS isoforms may contribute to the pathophysiology of bladder overactivity induced by BOO.
Objectives
To evaluate the therapeutic effect of once-per-week low-intensity extracorporeal shock wave therapy (Li-ESWT) on underactive bladder (UAB) in the streptozotocin-induced diabetic rat model.
Materials and Methods
Thirty-six female Sprague-Dawley rats were assigned into 3 groups: normal control (NC), diabetes control (DMC), and diabetes underwent Li-ESWT (DM Li-ESWT). The two DM groups received intraperitoneal 60 mg/kg streptozotocin injection to induce diabetes mellitus. The Li-ESWT was applied toward the pelvis of the rats started 4 weeks after the streptozotocin administration and lasted for 4 weeks. The shock wave therapy was given once-per-week with energy flux density of 0.02 mJ/mm2 at 3 Hz for 400 pulses. All rats were subjected to conscious cystometry, leak point pressure, ex-vivo organ bath study, histology, immunofluorescence, and western blot analysis.
Results
Conscious cystometry revealed voiding dysfunction in DMC group, whereas DM Li-ESWT group showed significantly improved voiding function in reduced post-void residual urine and increased leak point pressure compared to DMC group. Ex-vivo organ bath study showed that Li-ESWT enhances muscle contractile activity (MCA) of bladder and urethra in electrical field stimulation (EFS) and drug stimulation. Histologically, Li-ESWT significantly restored bladder morphology in reducing intravesical lumen area and increasing muscle proportion of the bladder wall. Western blot analysis showed higher smooth muscle actin (SMA) expression of bladder wall in DM Li-ESWT compared to DMC group. Immunofluorescence showed decreased nerve-ending distribution, and destroyed and shortened nerve fibers in DMC group and recovery of neuronal integrity and innervation in DM Li-ESWT group.
Conclusions
In conclusion, Li-ESWT ameliorated underactive bladder and urinary incontinence in the diabetic UAB rat model. The improvement seems to be the results of restoration of bladder and urethra structure and function by Li-ESWT. Li-ESWT is non-invasive and may become a better alternative therapy for UAB. Further investigations are warranted.
impressive. Severe side effects due to the ubiquitous presence of purinergic receptors will limit the use of P2X1 antagonists. However, since more and more attention is drawn on the afferent limb of the micturition reflex as the predominant cause for LUTS, further investigation of the changes of P2X2 or P2X3 receptor gene expression may be worthwhile. P2X1/GAPDH amplification ratio Obstructive Urodynamics Non-obstructive Urodynamics Irritative Urodynamics 1.05 Ϯ 0.71 0.98 Ϯ 0.3 Non-irritative Urodynamics 1.1 Ϯ 0.54 1.09 Ϯ 0.48 Tab. 1 Quantitative RT-PCR results of P2X1 purinergic receptor gene expression in correlation with urodynamic pattern (mean Ϯ SD)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.